EUCTR2018-003637-14-BE进行中（未招募）1 期
ocal injection of collagenase clostridium histolyticum (XiapexR) for refractory gastrointestinal strictures: an open-label pilot study.
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The patient is 18-90 years old
- •The patient suffers from a gastrointestinal stricture
- •The stricture is amenable for endoscopic dilation
- •The patient has undergone at least 1 previous endoscopic dilation for the same stricture within the last 3 months
- •The patient has signed the ICF
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •The patient is not fluent in Dutch
研究者
相似试验
已完成
2 期
Clostridium Histolyticum Collagenase Injection for Urethral DiseaseUrethral StrictureNCT02948842University of South Florida5
已完成
不适用
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens DiseaseDupuytren ContractureNCT03331926Jeppe Lange199
终止
早期 1 期
Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal StricturesStrictureEsophageal StrictureAnastomoticCollagenosisNCT03898661University Hospital, Ghent2
招募中
不适用
Extension of collagenase injection into the pretendinous cord in patients with Dupuytren contractureDupuytrenJPRN-UMIN000023119Department of Orthopaedic Surgery Shinshu University School of Medicine20
进行中（未招募）
不适用
The purpuse of this study is , in subjets affected by Dupuytren's and treated with local injection of Xiapex into fibrotic Dupuytren's cords , to promote patient confort and satisfaction by relieve pain due to Xiapex injection by the use of EMLA creamDupuytren s DiseaseMedDRA version: 14.1Level: SOCClassification code 10028395Term: Musculoskeletal and connective tissue disordersSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2012-005357-23-ITAUSL VITERBO